Involvement of p38 MAPK and Nrf2 in phenolic acid-induced P-form phenol sulfotransferase expression in human hepatoma HepG2 cells

Carcinogenesis

Volumn 27, Issue 5, 2006, Pages 1008-1017

  Yeh, Chi Tai ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARYL SULFOTRANSFERASE; DACTINOMYCIN; GALLIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENOL DERIVATIVE; TERT BUTYL HYDROPEROXIDE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL DAMAGE; CELL PROTECTION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENETIC TRANSFECTION; HEPATOMA CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ARYLSULFOTRANSFERASE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXIMIDE; DACTINOMYCIN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYBENZOIC ACIDS; NF-E2-RELATED FACTOR 2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33646196955     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi281     Document Type: Article

References (50)

1. Cooke,M.S., Evans,M.D., Dizdaroglu,M., and Lunec,J. (2003) Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J., 17, 1195-214.
2. Collins,A.R. (2005) Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am. J. Clin. Nutr., 81, 261-267.
3. Kensler,T.W. (1997) Chemoprevention by inducers of carcinogen detoxification enzymes. Environ. Health Perspect., 105, 965-970.
4. Ow,Y.Y., and Stupans,I. (2003) Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Curr. Drug Metab., 4, 241-248.
5. Yeh,C.T. and Yen,G.C. (2003) Effects of phenolic acids on human phenol sulfotransferase in relation to their antioxidant activity. J. Agric. Food Chem., 51, 1474-1479.
6. Runge-Morris,M.A. (1997) Regulation of expression of the rodent cytosolic sulfotransferases. FASEB J., 11, 109-117.
7. Richard,K., Hume,R., Kaptein,E., Stanley,E.L., Visser,T.J. and Coughtrie,M.W. (2001) Sulfation of thyroid hormone and dopamine during human development: Ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J. Clin. Endocrinol. Metab., 86, 2734-2742.
8. Maiti,S., Grant,S., Baker,S.M., Karanth,S., Pope,C.N. and Chen,G. (2004) Stress regulation of sulfotransferases in male rat liver. Biochem. Biophys. Res. Commun., 323, 235-241.
9. Davies,E., Tsang,C.W., Ghazali,A.R., Harris,R.M. and Waring,R.H. (2004) Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol. In Vitro, 18, 749-754.
10. Yeh,C.T.; Shih,P.S. and Yen,G.C. (2004) Synergistic effect of antioxidant phenolic acids on human phenol sulfotransferase activity. J. Agric. Food Chem., 52, 4139-4143.
11. Falany,C.N. (1991) Molecular enzymology of human liver cytosolic sulfotransferase. Trends Pharmacol. Sci., 44, 255-259.
12. Falany,J.L., Greer,H., Kovacs,T., Sorscher,E.J. and Falany,C.N. (2002) Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis. Biochem. J., 364, 115-120.
13. Ogawa,D., Shikata,K., Honke,K. et al. (2004) Cerebroside sulfotransferase deficiency ameliorates L-selectin- dependent monocyte infiltration in the kidney after ureteral obstruction. J. Biol. Chem., 279, 2085-2090.
14. Obata,T., Brown,G.E. and Yaffe,M.B. (2000) MAP kinase pathways activated by stress: The p38 MAPK pathway. Crit. Care Med., 28,67-77.
15. Kobayashi,M., and Yamamoto,M. (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signal, 7, 385-394.
16. Katsuoka,F., Motohashi,H., Engel,J.D. and Yamamoto,M. (2005) Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J. Biol. Chem., 280, 4483-4490.
17. Venugopal,R. and Jaiswal,A.K. (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:qUinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA, 93, 14960-14965.
18. Enomoto,A., Itoh,K., Nagayoshi,E., Haruta,J., Kimura,T., O'Connor,T., Harada,T. and Yamamoto,M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci., 59, 169-177.
19. Maiti,S. and Chen,G. (2003) Tamoxifen induction of aryl sulfotransferase and hydroxysteroid sulfotransferase in male and female rat liver and intestine. Drug Metab. Dispos., 31, 637-644.
20. Xie,T., Belinsky,M., Xu,Y. and Jaiswal,A.K. (1995) ARE- and TRE-mediated regulation of gene expression: Response to xenobiotics and antioxidants. J. Biol. Chem., 270, 6894-6900.
21. Yu,R., Lei,W., Mandlekar,S., Weber,M.J., Der,C.J., Wu,J. and Kong,A.T. (1999) Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem., 274, 27545-27552.
22. Shureiqi,I., Reddy,P. and Brenner,D.E. (2000) Chemoprevention: General perspective. Crit. Rev. Oncol. Hematol., 33, 157-167.
23. Kensler,T.W., Qian,G.S., Chen,J.G. and Groopman,J.D. (2003) Translational strategies for cancer prevention in liver. Nat. Rev. Cancer., 3, 321-329.
24. Abdel-Wahab,M.H., El-Mahdy,M.A., Abd-Ellah,M.F., Helal,G.K. Khalifa,F. and Hamada,F.M. (2003) Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat's heart. Pharmacol. Res., 48, 461-465.
25. Krajka-Kuzniak,V., Szaefer,H. and Baer-Dubowska,W. (2004) Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: Protocatechuic and tannic acids. Toxicol. Lett., 152, 117-126.
26. Wilkinson,J. and Clapper,M.L. (1997) Detoxification enzymes and chemoprevention. Proc. Soc. Exp. Biol. Med., 216, 192-200.
27. Steele,V.E., Kelloff,G.J., Balentine,D., Boone,C.W., Mehta,R., Baheri,D., Sigman,C.C., Zhu,S. and-Sharma,S. (2000) Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis, 21, 63-67.
28. Dashwood,R.H., Xu,M., Hernaez,J.F., Hasaniya,N., Youn,K. and Razzuk,A. (1999) Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc. Soc. Exp. Biol. Med., 220, 239-243.
29. Song,L.L., Kosmeder,J.W., Lee,S.K., Gerhauser,C. And Pezzuto,J.M. (1999) Cancer chemopreventive activity mediated by 4′-bromoflavone, a potent inducer of phase II detoxification enzymes. Cancer Res., 59, 578-585.
30. Tukey,R.H., Strassburg,C.P. and Mackenzie,P.I. (2002) Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol. Pharmacol., 62, 446-450.
31. Ahmad,N. and Mukhtar,H. (1999) Green tea polyphenols and cancer: biological mechanisms and practical implications. Nutr. Rev., 57, 78-83.
32. Duanmu,Z., Kocarek,T.A. and Runge-Morris,M. (2001) Transcriptional regulation of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by glucocorticoids. Drug Metab. Dispos., 29, 1130-1135.
33. Nguyen,T., Sherratt,P.J., Nioi,P., Yang,C.S. and Pickett,C.B. (2005) Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem., 280, 32485-32492.
34. Hong,F., Sekhar,K.R., Freeman,M.L. and Liebler,D.C. (2005) Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem., 280, 31768-31775.
35. Motohashi,H. and Yamamoto,M, (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med., 10, 549-557.
36. Iida,K., Itoh,K., Kumagai,Y., Oyasu,R., Hattori,K., Kawai,K., Shimazui,T., Akaza,H. and Yamamoto,M. (2004) Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res., 64, 6424-6431.
37. Chan,K., Han,X.D. and Kan,Y.W. (2001) An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA, 98, 4611-4616.
38. Prochaska,H.J., Santamaria,A.B. and Talalay,P. (1992) Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. USA, 89, 2394-2398.
39. Krajka-Kuzniak,V., Szaefer,H. and Baer-Dubowska,W. (2004) Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: Protocatechuic, and tannic acids. Toxicol. Lett., 152, 117-126.
40. Seger,R. and Krebs,E.G. (1995) The MAPK signaling cascade. FASEB J., 9, 726-735.
41. Kong,A.N., Owuor,E., Yu,R., Hebbar,V., Chen,C., Hu,R. and Mandlekar,S. (2001) Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile, response element (ARE/EpRE). Drug Metab. Rev., 33, 255-271.
42. Yu,R., Chen,C., Mo,Y.Y., Hebbar,V., Owuor,E.D., Tan,T.H. and Kong,A.N. (2000) Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem., 275, 39907-39913.
43. Yu,R., Jiao,J.J., Duh,J.L., Gudehithlu,K., Tan,T.H. and Kong,A.N. (1997) Activation of mitogen-activated protein kinases by green tea polyphenols: Potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis, 18, 451-456.
44. Shen,G., Hebbar,V., Nair,S., Xu,C., Li,W., Lin,W., Keum,Y.S., Han,J., Gallo,M.A. and Kong,A.N. (2004) Regulation of Nrf2 transactivation domain activity.The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J. Biol. Chem., 279, 23052-23060.
45. Di Simplicio,P. and Rossi,R. (1994) The time-course of mixed disulfide formation between GSH and proteins in rat blood after oxidative stress with tert-butyl hydroperoxide. Biochim. Biophys. Acta., 1199, 245-252.
46. Yen,G.C., Yeh,C.T. and Chen,Y.J. (2004) Protective effect of Mesona procumbens against tert-butyl hydroperoxide-induced acute hepatic damage in rats. J. Agric. Food Chem., 52, 4121-4127.
47. Nishino,H., Tokuda,H., Satomi,Y. et al. (2000) Cancer chemoprevention by phytochemicals and their related compounds. Asian Pac. J. Cancer Prev., 1, 49-55.
48. Zhang,Y. and Gordon,G.B. (2004) A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol. Cancer Ther., 3, 885-893.
49. Shahrzad,S., Aoyagi,K., Winter,A., Koyama,A. and Bitsch,I. (2001) Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr., 131, 1207-1210.
50. Shahrzad,S. and Bitsch,I. (2000) Determination of gallic, acid and its metabolites in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. B, 705, 1033-1043.